These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29800181)

  • 41. Prognostic value of preoperative carcinoembryonic antigen level in colorectal cancer in Tunisia.
    Gara S; Meziou S; Mtar A; Ghanem A; Harzallah L; Rahal K; Boussen H; Guemira F
    Tunis Med; 2012 Jan; 90(1):41-4. PubMed ID: 22311447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B
    Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lead time of carcinoembryonic antigen elevation in the postoperative follow-up of colorectal cancer did not affect the survival rate after recurrence.
    Chen CH; Hsieh MC; Lai CC; Yeh CY; Chen JS; Hsieh PS; Chiang JM; Tsai WS; Tang R; Changchien CR; Wang JY
    Int J Colorectal Dis; 2010 May; 25(5):567-71. PubMed ID: 20162425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing surveillance utilization and value in commercially insured patients with colorectal cancer.
    Suh K; Shankaran V; Bansal A
    Am J Manag Care; 2022 May; 28(5):e163-e169. PubMed ID: 35546589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thoracic recurrence in patients with curatively-resected colorectal cancer: incidence, risk factors, and value of chest CT as a postoperative surveillance tool.
    Lee JH; Park CM; Joo I; Suh YJ; Hwang EJ; Kim H; Goo JM
    Eur Radiol; 2019 Aug; 29(8):4303-4314. PubMed ID: 30350166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. First alert for recurrence during follow-up after potentially curative resection for colorectal carcinoma: CA 19-9 should be included in surveillance programs.
    Kawamura YJ; Tokumitsu A; Mizokami K; Sasaki J; Tsujinaka S; Konishi F
    Clin Colorectal Cancer; 2010 Jan; 9(1):48-51. PubMed ID: 20100688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer.
    McCall JL; Black RB; Rich CA; Harvey JR; Baker RA; Watts JM; Toouli J
    Dis Colon Rectum; 1994 Sep; 37(9):875-81. PubMed ID: 8076486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
    Chau I; Allen MJ; Cunningham D; Norman AR; Brown G; Ford HE; Tebbutt N; Tait D; Hill M; Ross PJ; Oates J
    J Clin Oncol; 2004 Apr; 22(8):1420-9. PubMed ID: 15007086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concordance with ASCO guidelines for surveillance after colorectal cancer treatment: a population-based analysis.
    Sisler JJ; Seo B; Katz A; Shu E; Chateau D; Czaykowski P; Wirtzfeld D; Singh H; Turner D; Martens P
    J Oncol Pract; 2012 Jul; 8(4):e69-79. PubMed ID: 23181004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-Term Outcome and Prognostic Factors of Sporadic Colorectal Cancer in Young Patients: A Large Institutional-Based Retrospective Study.
    Kim TJ; Kim ER; Hong SN; Chang DK; Kim YH
    Medicine (Baltimore); 2016 May; 95(19):e3641. PubMed ID: 27175682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of preoperative carcinoembryonic antigen and D-dimer concentrations in patients undergoing curative resection for colorectal cancer.
    Ojima Y; Harano M; Sumitani D; Yoshimitsu M; Okajima M
    Surg Today; 2021 Jul; 51(7):1108-1117. PubMed ID: 33386463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carcinoembryonic antigen testing after curative liver resection for synchronous liver metastasis of colorectal cancer: a Japanese multicenter analysis.
    Okazaki S; Baba H; Iwata N; Yamauchi S; Sugihara K
    Surg Today; 2017 Oct; 47(10):1223-1229. PubMed ID: 28439715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colonoscopy, imaging, and carcinoembryonic antigen: Comparison of guideline adherence to surveillance strategies in patients who underwent resection of colorectal cancer - A systematic review and meta-analysis.
    Dawood ZS; Hamad A; Moazzam Z; Alaimo L; Lima HA; Shaikh C; Munir MM; Endo Y; Pawlik TM
    Surg Oncol; 2023 Apr; 47():101910. PubMed ID: 36806402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathologic features and oncologic outcomes of colorectal cancer patients with extremely high carcinoembryonic antigen.
    Lee SY; Jo JS; Kim HJ; Kim CH; Ju JK; Kim YJ; Kim HR
    Int J Colorectal Dis; 2015 Jan; 30(1):63-9. PubMed ID: 25367182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important?
    Filiz AI; Sucullu I; Kurt Y; Karakas DO; Gulec B; Akin ML
    Clinics (Sao Paulo); 2009; 64(4):287-94. PubMed ID: 19488584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surveillance with serial serum carcinoembryonic levels detect colorectal cancer recurrences in patients who are initial nonsecretors.
    Holt A; Nelson RA; Lai L
    Am Surg; 2010 Oct; 76(10):1100-3. PubMed ID: 21105619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.
    Caglar M; Yener C; Karabulut E
    Int J Comput Assist Radiol Surg; 2015 Jul; 10(7):993-1002. PubMed ID: 25213271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases.
    Araujo RL; Gönen M; Allen P; DeMatteo R; Kingham P; Jarnagin W; D'Angelica M; Fong Y
    Ann Surg Oncol; 2015 Sep; 22(9):3087-93. PubMed ID: 25582745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.
    Sanli Y; Kuyumcu S; Ozkan ZG; Kilic L; Balik E; Turkmen C; Has D; Isik G; Asoglu O; Kapran Y; Adalet I
    Ann Nucl Med; 2012 Aug; 26(7):551-8. PubMed ID: 22644560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence of Recurrence and Time to Recurrence in Stage I to III Colorectal Cancer: A Nationwide Danish Cohort Study.
    Nors J; Iversen LH; Erichsen R; Gotschalck KA; Andersen CL
    JAMA Oncol; 2024 Jan; 10(1):54-62. PubMed ID: 37971197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.